Prediction: Pfizer Won’t Acquire Viking Therapeutics. Here’s Why.
Viking Therapeutics may be the next company to enter the red-hot weight loss space.
Near a 3-Year Low, Is This High-Yield Dividend Stock Worth Buying in April?
UPS has sold off heavily but remains an excellent long-term buy for patient investors.
Can Tesla Stock Reach $1,000 by 2030?
Bullish Tesla supporters are ready for the monster gains to continue.
1 Top Growth Stock to Buy and Hold Forever
This drugmaker looks unstoppable.
2 Artificial Intelligence (AI) Stocks That Could Go Parabolic
These two semiconductor companies could surge higher thanks to recent AI-related developments.